This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
ARCHIVED - PSL Assessment Report for Aluminum Salts
- List of Figures
- List of Tables
- List of Acronyms and Abbreviations
- Synopsis
- 1. Introduction
- 2. Summary of Information Critical to Assessment of "Toxic" Under CEPA 1999
- 2.1 Identity and physical/chemical properties
- 2.2 Entry characterization
- 2.3 Exposure Characterization
- 2.4 Effects characterization
- 3. Assessment of "Toxic" Under CEPA 1999
- 3.1 CEPA 1999 64(a) and 64(b) Environment
- 3.2 CEPA 1999 64(c): Human health
- 3.3 Conclusion
- References
- Appendix A
- Appendix B
- Appendix C
2. Summary of Information Critical to Assessment of "Toxic" Under CEPA 1999
- 2.1 Identity and physical/chemical properties
- 2.2 Entry characterization
- 2.3 Exposure Characterization
- 2.3.1 Environmental Fate
- 2.3.2 Environmental concentrations
- 2.3.2.1 Air
- 2.3.2.2 Water
- 2.3.2.3 Sediment
- 2.3.2.4 Soil
- 2.3.2.5 Biota
- 2.3.2.6 Food
- 2.3.2.7 Consumer products
- 2.3.2.8 Vaccines
- 2.3.3 Toxicokinetics: human and experimental animals
- 2.3.3.1 Absorption
- 2.3.3.1.1 Oral absorption
- 2.3.3.1.2 Dermal absorption
- 2.3.3.1.3 Inhalation absorption
- 2.3.3.1.4 Parenteral administration
- 2.3.3.1.5 Summary of estimates of aluminum bioavailability
- 2.3.3.1.6 Integrating bioavailability in human health risk assessment
- 2.3.3.2 Distribution
- 2.3.3.3 Elimination
- 2.4 Effects characterization
- 2.4.1 Ecotoxicology
- 2.4.2 Experimental mammal studies
- 2.4.2.1 Acute toxicity
- 2.4.2.2 Short-term toxicity (duration of exposure less than 90 days)
- 2.4.2.3 Subchronic and chronic toxicity (exposure duration greater than 90 days, non-cancer endpoints)
- 2.4.2.4 Reproductive and developmental toxicity
- 2.4.2.5 Carcinogenicity
- 2.4.2.6 Genotoxicity
- 2.4.3 Human studies
- 2.4.3.1 Human case studies of exposure to aluminum
- 2.4.3.2 Epidemiological studies of aluminum exposure via drinking water
- 2.4.3.3 Epidemiological investigations of exposure to aluminum in antacids, antiperspirants or food
- 2.4.3.4 Epidemiological investigations of exposure to aluminum in vaccines
- 2.4.3.5 Epidemiological investigations of occupational exposure to aluminum
- 2.4.4 Mode of action of toxic effects of aluminum
- Date modified: